AwardedCzechiaGoodsCZK 65,277,020
Léčivé přípravky s obsahem risankizumabu, tofacitinibu, apremilastu, mirikizumabu, deukravacitinibu, voklosporinu, siltuximabu
- Published
- Published 17 March 2025
- Deadline
- Closed 6 May 2025
Overview
Předmětem veřejné zakázky jsou průběžné dodávky léčivých přípravků s obsahem risankizumabu, tofacitinibu, apremilastu, mirikizumabu, deukravacitinibu, voklosporinu, siltuximabu po dobu 4 let dle aktuálních potřeb zadavatele.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 65,277,020
- Procedure
- Open
- Published
- 17 March 2025
- Deadline
- Closed
Immunosuppressive agents
Award outcome
- Awarded value
- CZK 52,829,572
- Award date
- 29 May 2025
- Contract period
- 14 May 2025 → 13 May 2029
- AbbVie s.r.o.
- Amgen s.r.o.
- Bristol-Myers Squibb spol. s r.o.
- PHOENIX lékárenský velkoobchod, s.r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
27 June 2025
Contract Award Notice
20 June 2025
Contract Notice
7 April 2025
Contract Notice
17 March 2025
Contracting authority
Fakultní nemocnice Hradec Králové
Procuring entityHradec Králové - Nový Hradec Králové, Czechia
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.